Skip to main content
Top
Published in: Reactions Weekly 1/2020

01-12-2020 | Melanoma | Case report

Tafamidis-meglumine

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Ishii T, et al. Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance. Clinical Therapeutics 42: 1728-1737 e6, No. 9, Sep 2020. Available from: URL: http://doi.org/10.1016/j.clinthera.2020.07.001 Ishii T, et al. Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance. Clinical Therapeutics 42: 1728-1737 e6, No. 9, Sep 2020. Available from: URL: http://​doi.​org/​10.​1016/​j.​clinthera.​2020.​07.​001
Metadata
Title
Tafamidis-meglumine
Various toxicities: 5 case reports
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-87799-3

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Adalimumab

Case report

Multiple drugs